platinum has been researched along with Lymphoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Hurford, M; Mekan, S; Simpkins, H | 1 |
| Hassan, MA; Jawaid, P; Kondo, T; Li, P; Misawa, M; Miyamoto, Y; Ogawa, R; Rehman, MU; Shimizu, T; Zhao, QL | 1 |
| Bachy, E; Bouafia-Sauvy, F; Gyan, E; Iltis, A; Ranchon, F; Rioufol, C; Salles, G; Sarkozy, C; Schwiertz, V; Tixier, F; Tournamille, JF; Vantard, N | 1 |
| Furuichi, M; Hassan, MA; Kondo, T; Miyamoto, Y; Shimizu, T; Wei, ZL; Yoshihisa, Y; Zhao, QL | 1 |
| Gastl, G; Steurer, M; Wagner, H | 1 |
| Henkel, H; Nagel, GA; von Heyden, HW; Weinstock, N | 1 |
| Gadia, M; Goel, R; Green, RM; Hugenholtz, H; Lamothe, A; Mikhael, NZ; Molepo, JM; Montpetit, VA; Redmond, MD; Stewart, DJ | 1 |
| Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W | 1 |
| el-Yazigi, A; Kanaan, I; Martin, CR; Siqueira, EB | 1 |
| Bergers, JJ; Claessen, A; de Groot, G; de Jong, WH; Franken, MA; Steerenberg, PA; Storm, G; van Hoesel, QG; Wubs, KL | 1 |
| Harder, HC; Lange, RC; Spencer, RP | 1 |
| Audette, RC; Connors, TA; Mandel, HG; Merai, K; Ross, WC | 1 |
2 trial(s) available for platinum and Lymphoma
| Article | Year |
|---|---|
Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Austria; Causality; Drug Utilization; Hemoglobins; Humans; Incidence; Lymphoma; Patient Care Management; Platinum; Prevalence; Prospective Studies; Risk Assessment; Risk Factors; Treatment Outcome | 2004 |
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure | 1995 |
10 other study(ies) available for platinum and Lymphoma
| Article | Year |
|---|---|
Downregulation of glutathione transferase π sensitizes lymphoma/leukaemia cells to platinum-based chemotherapy.
Topics: Antineoplastic Agents; Down-Regulation; Drug Resistance, Neoplasm; Glutathione Transferase; Humans; Leukemia; Lymphoma; Platinum | 2013 |
Effect of platinum nanoparticles on cell death induced by ultrasound in human lymphoma U937 cells.
Topics: Apoptosis; Humans; Lymphoma; Metal Nanoparticles; Platinum; U937 Cells | 2016 |
Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Humans; Kidney Diseases; Lymphoma; Male; Middle Aged; Platinum; Recurrence; Retrospective Studies; Young Adult | 2017 |
SOD/catalase mimetic platinum nanoparticles inhibit heat-induced apoptosis in human lymphoma U937 and HH cells.
Topics: Acrylic Resins; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Catalase; Cell Line, Tumor; DNA Fragmentation; Flow Cytometry; Free Radical Scavengers; Hot Temperature; Humans; Lymphoma; Nanoparticles; Peroxides; Platinum; Reactive Oxygen Species; Superoxide Dismutase; Superoxides; U937 Cells | 2011 |
[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].
Topics: Adult; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Kinetics; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ovarian Neoplasms; Platinum; Testicular Neoplasms | 1982 |
Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
Topics: Blood-Brain Barrier; Brain Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Lymphoma; Male; Medulloblastoma; Meningioma; Middle Aged; Neoplasms; Platinum | 1995 |
Cerebrospinal fluid content of manganese, platinum, and strontium in patients with cerebral tumors, leukemia, and other noncerebral neoplasms.
Topics: Adolescent; Adult; Brain Neoplasms; Breast Neoplasms; Female; Humans; Lymphoma; Male; Manganese; Platinum; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reference Values; Sarcoma; Strontium | 1990 |
Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.
Topics: Animals; Cell Line; Cisplatin; Drug Carriers; Drug Compounding; Drug Resistance; Kidney Diseases; Liposomes; Lymphoma; Mice; Platinum; Rats; Spleen; Tissue Distribution; Tumor Cells, Cultured | 1988 |
The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.
Topics: Adipose Tissue; Animals; Antineoplastic Agents; Brain; Female; Humans; Intestine, Small; Kidney; Liver; Lung; Lymphoma; Male; Myocardium; Neoplasm Transplantation; Platinum; Radioisotopes; Sarcoma 180; Skull; Spleen; Uterine Cervical Neoplasms | 1973 |
Studies on the mechanism of action of the tumour inhibitory triazenes.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Dealkylation; Leucine; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Microsomes; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Plasmacytoma; Platinum; Thymidine; Time Factors; Transplantation, Homologous; Triazenes; Tritium; Uridine | 1973 |